Molecular Neuro-oncology and Its Impact on the Clinical Management of Brain Tumors edited by O.D. Wiestler, U. Schlegel, J. Schramm.

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Wiestler, O.D (Editor), Schlegel, U. (Editor), Schramm, J. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1994.
Edition:1st ed. 1994.
Series:Recent Results in Cancer Research, 135
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Molecular Neuro-oncology
  • Human Neuroblastoma: Amplification of the N-myc Oncogene and Loss of a Putative Cancer-Preventing Gene on Chromosome 1p
  • Epidermal Growth Factor Receptor Gene and Its Transcripts in Glioblastomas
  • Type and Frequency of p53 Mutations in Tumors of the Nervous System and Its Coverings
  • Astrocytic Gliomas: Characterization on a Molecular Genetic Basis
  • Prognostic Relevance of Transforming Genes
  • Oncogene Transfer into the Brain
  • The O-2A Lineage: From Rats to Humans
  • Clinical Neuro-oncology
  • The Anti-Hu Syndrome: A Model Paraneoplastic Disorder
  • Radiosurgery/Stereotactic External Beam Radiotherapy for Malignant Brain Tumours: The Royal Marsden Hospital Experience
  • Interstitial Implant Radiosurgery of Brain Tumors: Radiobiology, Indications, and Results
  • Interstitial Brachytherapy of Malignant Gliomas: The Memorial Sloan-Kettering Cancer Center Experience
  • Aggressive Oligodendroglioma: A Chemosensitive Tumor
  • Chemotherapy of Malignant Gliomas
  • Interstitial Chemotherapy with Sustained-Release Polymer Systems for the Treatment of Malignant Gliomas
  • Primary Central Nervous System Lymphoma
  • Epidermal Growth Factor Receptor Expression in Human Malignant Glioma: In Vitro and In Vivo Effects of Application of Monoclonal Antibodies to the Epidermal Growth Factor Receptor
  • Target Cell Induced T Cell Activation with Bispecific Antibodies: A New Concept for Tumor Immunotherapy.